Lin, Li <br/><br/>
STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells.  [electronic resource] 

 -  International journal of oncology  Dec 2016 
 - 2265-2274 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2016.3728  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aldehyde Dehydrogenase--metabolism<br/>Anthraquinones--pharmacology<br/>CD24 Antigen--metabolism<br/>Cell Survival--drug effects<br/>Curcumin--analogs & derivatives<br/>Enzyme Activation<br/>Humans<br/>Hyaluronan Receptors--metabolism<br/>Neoplastic Stem Cells--metabolism<br/>Pancreatic Neoplasms--pathology<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>Spheroids, Cellular--drug effects<br/>Sulfonamides--pharmacology<br/>Tumor Cells, Cultured